Target intelligence / Profile preview

Immunoglobulin kappa variable 2-23 (IGKV2-23)

Target
IGKV2-23
Molecular classification
Variable domain of immunoglobulin light chain, Immunoglobulin superfamily (IgSF), Other
01

Overview

Immunoglobulin kappa variable 2-23 (IGKV2-23) encodes a variable region of the kappa light chain of human immunoglobulins. Immunoglobulins (antibodies) are heterodimeric proteins composed of two heavy and two light chains, produced by B lymphocytes and essential for adaptive immunity. The variable domain encoded by IGKV2-23 contributes to the antigen-binding site of kappa chain-containing antibodies, allowing specific recognition of diverse antigens. The diversity of antibodies is generated through somatic recombination of V, J, and C gene segments in the immunoglobulin loci, followed by somatic hypermutations that allow affinity maturation after exposure to antigen. IGKV2-23 belongs to the larger family of immunoglobulin variable region segments clustered in the kappa light chain locus on chromosome 2p11.2. The IGKV2 family is one of several kappa variable segment families used to generate the combinatorial diversity of the immune response[1][4].

Other names
IGKV2-23 gene
02

Biological functions

Antigen recognitionImmune response
03

Disease associations

Other

Beyond the preview

Go deeper on Immunoglobulin kappa variable 2-23 (IGKV2-23).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin kappa variable 2-23 (IGKV2-23).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call